440
R. Mankamna Kumari et al.
Tong WY et al (2018) Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon
nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. J Nanobiotechnol 16:38
Tortorella S, Karagiannis TC (2014) Transferrin receptor-mediated endocytosis: a useful target for
cancer therapy. J Membr Biol 247:291–307
Tosi G et al (2011) Investigation on mechanisms of glycopeptide nanoparticles for drug delivery
across the blood–brain barrier. Nanomedicine 6:423–436
Van Butsele K et al (2009) Synthesis and pH-dependent micellization of diblock copolymer
mixtures. J Colloid Interface Sci 329:235–243
Vonarbourg A, Passirani C, Saulnier P, Benoit J-P (2006) Parameters influencing the stealthiness
of colloidal drug delivery systems. Biomaterials 27:4356–4373
Wang B et al (2010) Inhibition of bacterial growth and intramniotic infection in a guinea pig model
of chorioamnionitis using PAMAM dendrimers. Int J Pharm 395:298–308
Weinstein JS et al (2010) Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous
system inflammatory pathologies, a review. J Cereb Blood Flow Metab 30:15–35
Wightman L, Kircheis R, Rössler V, Carotta S, Ruzicka R, Kursa M, Wagner E (2001) Different
behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene
Med 3:362–372
Wilson R (2008) The use of gold nanoparticles in diagnostics and detection. Chem Soc Rev 37:2028–
2045
Wind N, Holen I (2011) Multidrug resistance in breast cancer: from in vitro models to clinical
studies. Int J Breast Cancer, Article ID 967419
Wong KK, Liu X (2010) Silver nanoparticles—the real “silver bullet” in clinical medicine?
MedChemComm 1:125–131
Xiong F, Mi Z, Gu N (2011) Cationic liposomes as gene delivery system: transfection efficiency
and new application. Die Pharm-An Int J Pharm Sci 66:158–164
Yaméogo JB et al (2014) Self-assembled biotransesterified cyclodextrins as potential Artemisinin
nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution
assessment of unloaded nanoparticles. Eur J Pharm Biopharm 88:683–694
Yang K, Ma Y-Q (2010) Computer simulation of the translocation of nanoparticles with different
shapes across a lipid bilayer. Nat Nanotechnol 5:579–583
Yang X, Zhang Q, Wang Y, Chen H, Zhang H, Gao F, Liu L (2008) Self-aggregated nanoparticles
from methoxy poly (ethylene glycol)-modified chitosan: synthesis; characterization; aggregation
and methotrexate release in vitro. Colloids Surf B: Biointerfaces 61:125–131
Yen SK, Padmanabhan P, Selvan ST (2013) Multifunctional iron oxide nanoparticles for diagnostics,
therapy and macromolecule delivery. Theranostics 3:986–1003
Yoneki N et al (2015) One-pot facile preparation of PEG-modified PLGA nanoparticles: effects of
PEG and PLGA on release properties of the particles. Colloids Surf A 469:66–72
Yoo J-W, Irvine DJ, Discher DE, Mitragotri S (2011) Bio-inspired, bioengineered and biomimetic
drug delivery carriers. Nat Rev Drug Discov 10:521–535
Yuan H, Li J, Bao G, Zhang S (2010) Variable nanoparticle-cell adhesion strength regulates cellular
uptake. Phys Rev Lett 105:138101
Zhang S, Li J, Lykotrafitis G, Bao G, Suresh S (2009) Size-dependent endocytosis of nanoparticles.
Adv Mater 21:419–424
Zhang X-F, Liu Z-G, Shen W, Gurunathan S (2016) Silver nanoparticles: synthesis, characterization,
properties, applications, and therapeutic approaches. Int J Mol Sci 17:1534
Zhao X, Li H, Lee RJ (2008) Targeted drug delivery via folate receptors. Expert Opin Drug Deliv
5:309–319
Zhao Z, Li Y, Zhang Y, Chen A-Z, Li G, Zhang J, Xie M-B (2014) Development of silk fibroin
modified poly (l-lactide)–poly (ethylene glycol)–poly (l-lactide) nanoparticles in supercritical
CO2. Powder Technol 268:118–125
Zhou Z et al (2013) Linear-dendritic drug conjugates forming long-circulating nanorods for cancerdrug delivery. Biomaterials 34:5722–5735
R. Mankamna Kumari et al.
Tong WY et al (2018) Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon
nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. J Nanobiotechnol 16:38
Tortorella S, Karagiannis TC (2014) Transferrin receptor-mediated endocytosis: a useful target for
cancer therapy. J Membr Biol 247:291–307
Tosi G et al (2011) Investigation on mechanisms of glycopeptide nanoparticles for drug delivery
across the blood–brain barrier. Nanomedicine 6:423–436
Van Butsele K et al (2009) Synthesis and pH-dependent micellization of diblock copolymer
mixtures. J Colloid Interface Sci 329:235–243
Vonarbourg A, Passirani C, Saulnier P, Benoit J-P (2006) Parameters influencing the stealthiness
of colloidal drug delivery systems. Biomaterials 27:4356–4373
Wang B et al (2010) Inhibition of bacterial growth and intramniotic infection in a guinea pig model
of chorioamnionitis using PAMAM dendrimers. Int J Pharm 395:298–308
Weinstein JS et al (2010) Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous
system inflammatory pathologies, a review. J Cereb Blood Flow Metab 30:15–35
Wightman L, Kircheis R, Rössler V, Carotta S, Ruzicka R, Kursa M, Wagner E (2001) Different
behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene
Med 3:362–372
Wilson R (2008) The use of gold nanoparticles in diagnostics and detection. Chem Soc Rev 37:2028–
2045
Wind N, Holen I (2011) Multidrug resistance in breast cancer: from in vitro models to clinical
studies. Int J Breast Cancer, Article ID 967419
Wong KK, Liu X (2010) Silver nanoparticles—the real “silver bullet” in clinical medicine?
MedChemComm 1:125–131
Xiong F, Mi Z, Gu N (2011) Cationic liposomes as gene delivery system: transfection efficiency
and new application. Die Pharm-An Int J Pharm Sci 66:158–164
Yaméogo JB et al (2014) Self-assembled biotransesterified cyclodextrins as potential Artemisinin
nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution
assessment of unloaded nanoparticles. Eur J Pharm Biopharm 88:683–694
Yang K, Ma Y-Q (2010) Computer simulation of the translocation of nanoparticles with different
shapes across a lipid bilayer. Nat Nanotechnol 5:579–583
Yang X, Zhang Q, Wang Y, Chen H, Zhang H, Gao F, Liu L (2008) Self-aggregated nanoparticles
from methoxy poly (ethylene glycol)-modified chitosan: synthesis; characterization; aggregation
and methotrexate release in vitro. Colloids Surf B: Biointerfaces 61:125–131
Yen SK, Padmanabhan P, Selvan ST (2013) Multifunctional iron oxide nanoparticles for diagnostics,
therapy and macromolecule delivery. Theranostics 3:986–1003
Yoneki N et al (2015) One-pot facile preparation of PEG-modified PLGA nanoparticles: effects of
PEG and PLGA on release properties of the particles. Colloids Surf A 469:66–72
Yoo J-W, Irvine DJ, Discher DE, Mitragotri S (2011) Bio-inspired, bioengineered and biomimetic
drug delivery carriers. Nat Rev Drug Discov 10:521–535
Yuan H, Li J, Bao G, Zhang S (2010) Variable nanoparticle-cell adhesion strength regulates cellular
uptake. Phys Rev Lett 105:138101
Zhang S, Li J, Lykotrafitis G, Bao G, Suresh S (2009) Size-dependent endocytosis of nanoparticles.
Adv Mater 21:419–424
Zhang X-F, Liu Z-G, Shen W, Gurunathan S (2016) Silver nanoparticles: synthesis, characterization,
properties, applications, and therapeutic approaches. Int J Mol Sci 17:1534
Zhao X, Li H, Lee RJ (2008) Targeted drug delivery via folate receptors. Expert Opin Drug Deliv
5:309–319
Zhao Z, Li Y, Zhang Y, Chen A-Z, Li G, Zhang J, Xie M-B (2014) Development of silk fibroin
modified poly (l-lactide)–poly (ethylene glycol)–poly (l-lactide) nanoparticles in supercritical
CO2. Powder Technol 268:118–125
Zhou Z et al (2013) Linear-dendritic drug conjugates forming long-circulating nanorods for cancerdrug delivery. Biomaterials 34:5722–5735